Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling

Journal of Virology

Volumn 86, Issue 17, 2012, Pages 9311-9322

  Wang, Dang ^a   Fang, Liurong ^a   Li, Kui ^b   Zhong, Huijuan ^a   Fan, Jinxiu ^a   Ouyang, Chao ^a   Zhang, Huan ^a   Duan, Erzhen ^a   Luo, Rui ^a   Zhang, Zhongming ^a   Liu, Xiangtao ^c   Chen, Huanchun ^a   Xiao, Shaobo ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA1 INTERFERON; BETA INTERFERON; DOUBLE STRANDED RNA; GAMMA INTERFERON INDUCIBLE PROTEIN 10; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON STIMULATED GENE 54 PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PROTEINASE; PROTEINASE 3C; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INHIBITION; FOOT AND MOUTH DISEASE VIRUS; GENE EXPRESSION REGULATION; IMMUNE EVASION; INNATE IMMUNITY; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; SWINE; UPREGULATION; VIRUS INHIBITION; VIRUS SURVIVAL;

ANIMALS; CYSTEINE ENDOPEPTIDASES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNITY, INNATE; INTERFERONS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NF-KAPPA B; PROTEOLYSIS; SIGNAL TRANSDUCTION; SWINE; SWINE DISEASES; VIRAL PROTEINS;

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; PICORNAVIRIDAE;

EID: 84866144289     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00722-12     Document Type: Article

References (61)

1. Ashida H, et al. 2010. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat. Cell Biol. 12: 66-73.
2. Barral PM, et al. 2007. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 81: 3677-3684.
3. Barral PM, Sarkar D, Fisher PB, Racaniello VR. 2009. RIG-I is cleaved during picornavirus infection. Virology 391: 171-176.
4. Basler CF, et al. 2003. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77: 7945-7956.
5. Belsham GJ, McInerney GM, Ross-Smith N. 2000. Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. J. Virol. 74: 272-280.
6. Birtley JR, et al. 2005. Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity. J. Biol. Chem. 280: 11520-11527.
7. Bloor S, et al. 2008. Signal processing by its coil zipper domain activates IKK gamma. Proc. Natl. Acad. Sci. U. S. A. 105: 1279-1284.
8. Chen Z, et al. 2007. Ubiquitination and proteasomal degradation of interferon regulatory factor-3 induced by Npro from a cytopathic bovine viral diarrhea virus. Virology 366: 277-292.
9. Chinsangaram J, Piccone ME, Grubman MJ. 1999. Ability of foot-andmouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J. Virol. 73: 9891-9898.
10. Clementz MA, et al. 2010. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J. Virol. 84: 4619-4629.
11. de Los Santos T, de Avila Botton S, Weiblen R, Grubman MJ. 2006. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 80: 1906-1914.
12. de Los Santos T, Diaz-San Segundo F, Grubman MJ. 2007. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J. Virol. 81: 12803-12815.
13. de los Santos T, Segundo FD, Zhu J, Koster M, Dias CC, Grubman MJ. 2009. A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function. J. Virol. 83: 1800-1810.
14. Devaraj SG, et al. 2007. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 282: 32208-32221.
15. Dias CC, Moraes MP, Segundo FD, de los Santos T, Grubman MJ. 2011. Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus. J. Interferon Cytokine Res. 31: 227-236.
16. Diaz-San Segundo F, et al. 2011. Antiviral activity of bovine type III interferon against foot-and-mouth disease virus. Virology 413: 283-292.
17. Escarmis C, Perales C, Domingo E. 2009. Biological effect of Muller's Ratchet: distant capsid site can affect picornavirus protein processing. J. Virol. 83: 6748-6756.
18. Fliss PM, et al. 2012. Viral mediated redirection of NEMO/IKKgamma to autophagosomes curtails the inflammatory cascade. PLoS Pathog. 8: e1002517. doi:10.1371/journal.ppat.1002517.
19. Foeger N, Glaser W, Skern T. 2002. Recognition of eukaryotic initiation factor 4G isoforms by picornaviral proteinases. J. Biol. Chem. 277: 44300-44309.
20. Gitlin L, et al. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U. S. A. 103: 8459-8464.
21. Golde WT, Nfon CK, Toka FN. 2008. Immune evasion during foot-andmouth disease virus infection of swine. Immunol. Rev. 225: 85-95.
22. Grubman MJ, Baxt B. 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17: 465-493.
23. Grubman MJ, Moraes MP, Diaz-San Segundo F, Pena L, de los Santos T. 2008. Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. FEMS Immunol. Med. Microbiol. 53: 8-17.
24. Grubman MJ, Zellner M, Bablanian G, Mason PW, Piccone ME. 1995. Identification of the active-site residues of the 3C proteinase of foot-andmouth disease virus. Virology 213: 581-589.
25. Husser L, Alves MP, Ruggli N, Summerfield A. 2011. Identification of the role of RIG-I, MDA-5 and TLR3 in sensing RNA viruses in porcine epithelial cells using lentivirus-driven RNA interference. Virus Res. 159: 9-16.
26. Kato H, Takahasi K, Fujita T. 2011. RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol. Rev. 243: 91-98.
27. Kato H, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
28. Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7: 131-137.
29. Kawai T, et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5- mediated type I interferon induction. Nat. Immunol. 6: 981-988.
30. Kim O, Sun Y, Lai FW, Song C, Yoo D. 2010. Modulation of type I interferon induction by porcine reproductive and respiratory syndrome virus and degradation of CREB-binding protein by non-structural protein 1 in MARC-145 and HeLa cells. Virology 402: 315-326.
31. Klump W, Marquardt O, Hofschneider PH. 1984. Biologically active protease of foot and mouth disease virus is expressed from cloned viral cDNA in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 81: 3351-3355.
32. Lei X, et al. 2010. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 84: 8051-8061.
33. Lei X, et al. 2011. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 85: 8811-8818.
34. Makris C, Roberts JL, Karin M. 2002. The carboxyl-terminal region of IkappaB kinase gamma (IKKgamma) is required for full IKK activation. Mol. Cell. Biol. 22: 6573-6581.
35. Mason PW, Grubman MJ, Baxt B. 2003. Molecular basis of pathogenesis of FMDV. Virus Res. 91: 9-32.
36. Meylan E, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
37. Moraes MP, et al. 2007. Enhanced antiviral activity against foot-andmouth disease virus by a combination of type I and II porcine interferons. J. Virol. 81: 7124-7135.
38. Mukherjee A, et al. 2011. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 7: e1001311. doi:10.1371/journal.ppat.1001311.
39. Papon L, et al. 2009. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 393: 311-318.
40. Qu L, et al. 2011. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog. 7:e1002169. doi:10.1371/journal.ppat.1002169.
41. Scheidereit C. 2006. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25: 6685-6705.
42. Sen A, Feng N, Ettayebi K, Hardy ME, Greenberg HB. 2009. IRF3 inhibition by rotavirus NSP1 is host cell and virus strain dependent but independent of NSP1 proteasomal degradation. J. Virol. 83: 10322-10335.
43. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
44. Shi X, et al. 2011. The nonstructural protein 1 papain-like cysteine protease was necessary for porcine reproductive and respiratory syndrome virus nonstructural protein 1 to inhibit interferon-beta induction. DNA Cell Biol. 30: 355-362
45. Song C, Krell P, Yoo D. 2010. Nonstructural protein 1alpha subunitbased inhibition of NF-kappaB activation and suppression of interferonbeta production by porcine reproductive and respiratory syndrome virus. Virology 407: 268-280.
46. Summerfield A, Guzylack-Piriou L, Harwood L, McCullough KC. 2009. Innate immune responses against foot-and-mouth disease virus: current understanding and future directions. Vet. Immunol. Immunopathol. 128: 205-210.
47. Sun Z, Chen Z, Lawson SR, Fang Y. 2010. The cysteine protease domain of porcine reproductive and respiratory syndrome virus nonstructural protein 2 possesses deubiquitinating and interferon antagonism functions. J. Virol. 84: 7832-7846.
48. Vakharia VN, Devaney MA, Moore DM, Dunn JJ, Grubman MJ. 1987. Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. J. Virol. 61: 3199-3207.
49. Wang D, et al. 2011. The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J. Virol. 85: 3758-3766.
50. Wang D, et al. 2008. Molecular cloning and functional characterization of porcine IFN-beta promoter stimulator 1 (IPS-1). Vet. Immunol. Immunopathol. 125: 344-353.
51. Wang D, et al. 2011. Foot-and-mouth disease virus (FMDV) leader proteinase negatively regulates the porcine interferon-lambda1 pathway. Mol. Immunol. 49: 407-412.
52. Wang D, et al. 2010. Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels. Biochem. Biophys. Res. Commun. 399: 72-78.
53. Xiong Y, Lin M, Yuan B, Yuan T, Zheng C. 2009. Expression of exogenous IFN-alpha by bypassing the translation block protects cells against FMDV infection. Antiviral Res. 84: 60-66.
54. Xu LG, et al. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19: 727-740.
55. Yang F, et al. 2004. The zinc finger mutation C417R of I-kappa B kinase gamma impairs lipopolysaccharide- and TNF-mediated NF-kappa B activation through inhibiting phosphorylation of the I-kappa B kinase beta activation loop. J. Immunol. 172: 2446-2452.
56. Yang Y, et al. 2007. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl. Acad. Sci. U. S. A. 104: 7253-7258.
57. Yao Q, Huang Q, Cao Y, Qian P, Chen H. 2008. Porcine interferongamma protects swine from foot-and-mouth disease virus (FMDV). Vet. Immunol. Immunopathol. 122: 309-311.
58. Yoneyama M, Fujita T. 2007. RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. Cytokine Growth Factor Rev. 18: 545-551.
59. Yu S, et al. 2010. Hepatitis B virus polymerase inhibits RIG-I- and Tolllike receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J. Gen. Virol. 91: 2080-2090.
60. Zhao T, et al. 2007. The NEMO adaptor bridges the nuclear factorkappaB and interferon regulatory factor signaling pathways. Nat. Immunol. 8: 592-600.
61. Zheng D, Chen G, Guo B, Cheng G, Tang H. 2008. PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res. 18: 1105-1113.